Projects per year
Fingerprint
Dive into the research topics where Division of Pharmacology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Stefanie Boigenzahn
- Karl Landsteiner University of Health Sciences, Division of Pharmacology - Former employee
Person
-
Clio-Melina Denk
- Karl Landsteiner University of Health Sciences, Division of Pharmacology - Former employee
Person
-
AGEs: Role of Dietary Glycation Products in Allergic Sensitization
Geiselhart, S. (PI)
01.09.2024 → 31.08.2025
Project: Funded Research
-
Breast Cancer: Uncovering new checkpoints in natural killer cells to prevent breast cancer metastasis
Witalisz-Siepracka, A. (PI), Vallet, S. (CoPI) & Gotthardt, D. (CoPI)
Gesellschaft für Forschungsförderung NÖ
01.12.2022 → 30.11.2025
Project: Funded Research
-
JAK2 inhibitors: JAK2 inhibitors and the innate immune response in mutant CALR-driven MPNs
Stoiber-Sakaguchi, D. (PI), Podar, K. (CoPI) & Kollmann, K. (CoPI)
Gesellschaft für Forschungsförderung NÖ
01.01.2022 → 31.12.2025
Project: Funded Research
Research output
-
A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia
Edtmayer, S., Witalisz-Siepracka, A., Zdársky, B., Heindl, K., Weiss, S., Eder, T., Dutta, S., Graichen, U., Klee, S., Sharif, O., Wieser, R., Győrffy, B., Poli, V., Casanova, E., Sill, H., Grebien, F. & Stoiber, D., 28 May 2024, In: Cell Death and Disease. 15, 5, p. 369 369.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity
Lind, J., Aksoy, O., Prchal-Murphy, M., Fan, F., Fulciniti, M., Stoiber, D., Bakiri, L., Wagner, E. F., Zwickl-Traxler, E., Sattler, M., Kollmann, K., Vallet, S. & Podar, K., 19 Aug 2024, In: Blood Cancer Journal. 14, 1, 138.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels
Tinchon, A., Brait, J., Klee, S., Graichen, U., Baumgartner, C., Friedrich, O., Freydl, E., Oberndorfer, S., Struhal, W., Hain, B., Waiß, C. & Stoiber, D., 12 Jul 2024, In: Frontiers in Pharmacology. 15, 1377232.Research output: Journal article (peer-reviewed) › Journal article
Open Access
Prizes
-
-
-
Würdigungspreis des Bundesministerium für Bildung, Wissenschaft und Forschung
Harm, T. (Recipient), Nov 2023
Prize: Honorary award
Activities
-
Uncovering new Natural Killer cell immune checkpoints in the context of triple-negative breast cancer
Harm, T. (Speaker)
Feb 2024Activity: Talk or presentation › Science to science: (Invited) talk/oral presentation
-
Unraveling the tumor-supressive role of STAT3β in acute myeloid leukemia
Edtmayer, S. R. (Speaker)
29 Sept 2023 → 30 Sept 2023Activity: Talk or presentation › Science to science: (Invited) talk/oral presentation
-
The balance between STAT3 isoforms as essential feature in acute myeloid leukemia
Weiß, S. (Speaker)
14 Sept 2023Activity: Talk or presentation › Science to science: (Invited) talk/oral presentation
Press/Media
-
Die Killerzellen kämpfen lassen
28.05.2024
1 item of Media coverage
Press/Media: Newspaper/magazine › Online
-
60 Sekunden mit Agnieszka Witalisz | Krebsforschung
12.01.2024
1 item of Media coverage
Press/Media: Social media/Blog